Target_Trader
Posted - 04/25/24
$URGN gap fill at 12 waiting to load their
G101SPM
Posted - 04/25/24
@satsandstocks per request: $URGN at $13.98 carries SPM 81.25 suggestion neural reading; $DAWN at $13.25 carries SPM 78.99 tag.
satsandstocks
Posted - 04/25/24
$URGN This keep coming back into $14 range - impressed ! Heavy into it
sem__sem
Posted - 04/23/24
@Numbersandfacts @benji1298 Respect! I started my share holding 2019 March and bought $URGN and it just went down and down until last summer when BO rumours arrived and made a nice win. I still have it but just a tiny position. Due to averaging down my position grew to 1 of the biggest of my portfolio - a bit same like with $MCRB but here I only started 5 months ago..
YungBull100
Posted - 04/22/24
$URGN another week, another Jelmyto dispensed at the hospital. Keep those revs comin
AboveTheHorizon
Posted - 04/20/24
$URGN fire sale here Friday and the week before. This is worth $38-$60. Also on top BO list for this year. Accumulate in these low ranges.
Stock_Titan
Posted - 04/17/24
$URGN UroGen Announces New Data Presentations at the American Urological Association 2024 Annual Meeting Highlighting Clinical Benefits of Our Portfolio for Urothelial Cancers
https://www.stocktitan.net/news/URGN/uro-gen-announces-new-data-presentations-at-the-american-urological-4to7y2ocb89l.html
AboveTheHorizon
Posted - 04/15/24
$URGN wen buy out $60
Cellphones6213
Posted - 04/15/24
$URGN I’m having a great day
Cellphones6213
Posted - 04/15/24
$URGN look at this volume! I mean not a lot for some stocks but for this one lots of fun!
satsandstocks
Posted - 04/15/24
$URGN i just feel like adding more here 14.50 - but that might be my over exposure. Will wait to see how it closes.
UBER_ONE
Posted - 04/15/24
$SNGX $URGN FDA !!!!!! Congratulation
UBER_ONE
Posted - 04/15/24
$URGN
DonCorleone77
Posted - 04/15/24
$URGN UroGen Pharma announces FDA acceptance of UGM-103 IND UroGen Pharma announced the FDA accepted the company's investigational new drug, or IND, application for UGN-103, a next-generation novel mitomycin-based formulation for low-grade intermediate-risk non-muscle invasive bladder cancer.
UBER_ONE
Posted - 04/15/24
$ONVO $SNGX $URGN 3 TOP RUNNER today
RonIsWrong
Posted - 04/15/24
$URGN UroGen Announces FDA Acceptance of Investigational New Drug Application for UGN-103, a Next Generation Mitomycin-Based Formulation for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
UBER_ONE
Posted - 04/15/24
$SNGX another FDA Grants $URGN
Stock_Titan
Posted - 04/15/24
$URGN UroGen Announces FDA Acceptance of Investigational New Drug Application for UGN-103, a Next Generation Mitomycin-Based Formulation for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
https://www.stocktitan.net/news/URGN/uro-gen-announces-fda-acceptance-of-investigational-new-drug-aeooznlx8mtd.html
Paul_Volcker
Posted - 04/14/24
$URGN Any news to account for the 3.5X RelVol on Friday? Can't find anything - thanks in advance.
Night_Owl_Biotech
Posted - 04/14/24
We've been following $URGN since Jelmyto was first approved in April 2020. It is often rumored URGN is about to be acquired. On March 25, 2024 URGN shot up 16% at the open (we guessed due to an imminent transaction). Just last Friday April 12, 2024 URGN shot up again 14% on an otherwise dismal day for biotech. The attachment is a simple snapshot of URGN trading over the last 6 weeks or so. We have no idea if URGN is about to be acquired. However, for those who like volatility, if no announcement comes tomorrow morning then it is likely URGN trading will be volatile (either much higher or lower). Good luck. This is not investment advice. Our attachment could be misleading or outright inaccurate. We will soon post a simple revenue multiple driven (potential) valuation analysis of $DAWN
Night_Owl_Biotech
Posted - 04/14/24
Attached (left) = all acquisitions of comm'l-stage non-oncology biopharmas acquired since 1/1/17. It's our non-professional experience most new therapies are acquired within 1 to 2 years post approval. We do not recall many acquisitions of comm'l-stage bios w/approvals post 3 years (pls lets us know if we are missing any). (Right) = all non-oncology bios with a FDA approval over the last 4 years (market cap $100MM+). If we had to guess (for entertainment), we suspect $VALN would be acquired sooner rather than later since Pfizer already owns a good piece of VALN & VALN's new vaccine should be a good fit. VALN cash includes $103MM from the sale of PRV. Takeda sells Vonoprazan in Japan making $PHAT an obvious candidate. $TARS is 1 of the best performers in biopharma the last 12 months (excl. recent financing). Next step is a B/O (a guess). Last, watch $URGN as Friday's trading was highly unusual. B/O candidate? This is not investment advice. Be careful, our data may be wrong too.
RonIsWrong
Posted - 04/13/24
$URGN bought a bunch back yesterday as well.
Gracias, @WSRX
Sduteil
Posted - 04/12/24
$URGN Almost 8K shares traded after hours so far….highly unusual for this stock…
Horrible day for stocks and this moving hard in a good way.
Stocksrunner
Posted - 04/12/24
As the trading week comes to a close, we saw several companies stage impressive rallies from their opening prices to end the day much higher. Here's a rundown of the top performers: $YYAI - Opened at $1.02 and closed at $1.50, a remarkable 47.06% surge. $CNEY - Climbed from an opening of $0.99 to a closing price of $1.16, a 17.17% gain. $ADPT - Saw a 16.22% increase, rising from $2.59 at the open to $3.01 at the close. $URGN - Jumped 15.36% on the day, starting at $13.09 and finishing at $15.10. $XFOR - Ended 10.74% higher than its $1.21 open, closing at $1.34. Keep an eye on these movers for potential opportunities in the market! 📈💼
Sduteil
Posted - 04/12/24
$URGN Checkout the volume today… 1.2 million ! Way above 90 day average.
Not going to say it but big volume out of the blue on a Friday.. end of day…. Smells very familiar.
GLTA.
Sduteil
Posted - 04/12/24
$URGN Well, well, well! What a nice day finally for URGN!
Had to average down this past week! This is a hidden gem IMO! This has takeout written all over it! I just keep adding.
Cellphones6213
Posted - 04/12/24
$URGN I am so long on this stock it’s not even funny. But just for the sake of a swing trade: it has a huge fda approval date approaching in the next 12 months, and when the phase 3 trials for said drug had good results this stock climbed to $24. Just imagine the run up when that date is announced. Very exciting!
AboveTheHorizon
Posted - 04/12/24
$URGN Thanks for heads up on this yesterday @WSRX
CH_Expat
Posted - 04/12/24
$URGN Green for the first time after three buys. More please.
WSRX
Posted - 04/11/24
$URGN such a steal down here